Join us for a half-day, virtual seminar focused on the various, complex aspects of Extractables & Leachables Testing. Industry experts will guide you through a deep dive into the latest trends, technology and approaches for E&L testing.

Don’t miss this informative, technical seminar filled with presentations from Eli Lilly, AstraZeneca, Eurofins and Safe Bridge Consulting.

Agenda

11:00am-12:00pm (EDT)	Extractable and Leachables Testing: Where to Start? Kevin Wells, Group Leader, Eurofins BioPharma Product Testing
12:00pm-12:30pm	Case study: Addressing Headspace Migration of Leachable into Drug Products Stephen Warren, Senior Scientist, Analytical Sciences, AstraZeneca
12:30pm-1:15pm	Establishing Permitted Daily Exposure (PDE) Values for Extractables & Leachables into Drug Products Allan W. Ader, Ph.D., DABT, Co-founder and Managing Director of SafeBridge Consultants, Inc.
1:15pm-1:45pm	The Making of a LEAN E&L Laboratory Andrew Blakinger, Manager, Extractables & Leachables Testing, Eurofins BioPharma Product Testing
1:45pm-2:15pm	Case Study: Combating Nitrosamines in Packaging Atish Sen, Ph.D., Staff Scientist, Analytical Sciences Inhalation Product Development, AstraZeneca \| Operations P&D
2:15pm-3:00pm	Looking Past COVID Toward New Horizons: Challenges with Ultrarapid Development, Manufacturing and Deployment of Pharmaceutical Countermeasures for Unanticipated and Unmet Medical Needs Doug Kiehl, Research Advisor, Eli Lilly

First Name:

Last Name:

Job Title:

Email Address:

Company Name:

Country:

Address:

City:

State:

Postal Code:

Industry:

Do you currently use a contract laboratory or are you considering outsourcing Extractables & Leachables testing in the future?

What best describes the department you work in?:

How did you hear about this webinar?:

Opt in to receive future invitations and industry news from Eurofins.

I have read and accept the Privacy Notice:

Don’t miss this informative, technical seminar filled with presentations from Eli Lilly, AstraZeneca, Eurofins and Safe Bridge Consulting.

Agenda

Presentation begins at: 00:00	Extractable and Leachables Testing: Where to Start? Kevin Wells, Group Leader, Eurofins BioPharma Product Testing
Presentation begins at: 00:59	Case study: Addressing Headspace Migration of Leachable into Drug Products Stephen Warren, Senior Scientist, Analytical Sciences, AstraZeneca
Presentation begins at: 01:33	Establishing Permitted Daily Exposure (PDE) Values for Extractables & Leachables into Drug Products Allan W. Ader, Ph.D., DABT, Co-founder and Managing Director of SafeBridge Consultants, Inc.
Presentation begins at: 02:21	The Making of a LEAN E&L Laboratory Andrew Blakinger, Manager, Extractables & Leachables Testing, Eurofins BioPharma Product Testing
Presentation begins at: 02:44	Case Study: Combating Nitrosamines in Packaging Atish Sen, Ph.D., Staff Scientist, Analytical Sciences Inhalation Product Development, AstraZeneca \| Operations P&D
Presentation begins at: 03:17	Looking Past COVID Toward New Horizons: Challenges with Ultrarapid Development, Manufacturing and Deployment of Pharmaceutical Countermeasures for Unanticipated and Unmet Medical Needs Doug Kiehl, Research Advisor, Eli Lilly

Presenters:

	Name Title Eurofins BioPharma Product Testing
Abstract goes here
	Name Title Eurofins BioPharma Product Testing
Abstract goes here
	Name Title Eurofins BioPharma Product Testing
Abstract goes here
	Name Title Eurofins BioPharma Product Testing
Abstract goes here

Moderator:

	Andrew Blakinger Title Eurofins BioPharma Product Testing
Abstract goes here

Homepage \| Search \| Careers \| Contact Us
Cookie Notice \| Web Privacy Notice \| Update Preferences		Copyright Eurofins USA © - All Rights Reserved